Nir Barzilai

geneticistresearcheranti-aging practitioner and activistageingVerified via Wikidata

Researcher who has argued that Metformin is geroprotective and has discussed it on Peter Attia's podcast.

Mentioned in 15 videos
Born
January 1, 1955, Haifa
Nationality
Israel, United States
Affiliation
Albert Einstein College of Medicine
Field
ageing, human genetics, longevity
Education
Technion – Israel Institute of Technology
Awards
Irving S. Wright Award of Distinction

Videos Mentioning Nir Barzilai

197 - The science of obesity & how to improve nutritional epidemiology | David Allison, Ph.D

197 - The science of obesity & how to improve nutritional epidemiology | David Allison, Ph.D

Peter Attia MD

Mentioned by Peter Attia as an early listener of the podcast, being in league with David Allison.

175 - The biology of aging, rapamycin, and other interventions that target the aging process

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Peter Attia MD

A researcher whose work on centenarians shows they get chronic diseases later in life, rather than living longer with them, suggesting a 'phase shift' in disease onset.

171- Longevity science: caloric restriction studies, aging biomarkers & possible longevity molecules

171- Longevity science: caloric restriction studies, aging biomarkers & possible longevity molecules

Peter Attia MD

A researcher known for his strong advocacy of Metformin's benefits, even for healthy individuals, which differs from Steve's more skeptical view.

Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects

Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects

Andrew Huberman

Likely the senior Principal Investigator (PI) on the TAME trial.

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

Director of the Institute for Aging Research at Albert Einstein College of Medicine, known for longevity gene projects and research into Metformin.

Health & Longevity: A Conversation with Peter Attia (Episode #328)

Health & Longevity: A Conversation with Peter Attia (Episode #328)

Sam Harris

Researcher at Albert Einstein College of Medicine studying centenarians and exceptional longevity.

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

Peter Attia MD

Researcher who leads the TAME study, aiming to evaluate the benefits of Metformin in non-diabetics for aging-related diseases.

The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show

The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show

Tim Ferriss

A researcher at Einstein who has championed the TAME human clinical trial for Metformin.

#103 – Looking back on the first 99 episodes: Strong Convictions, Loosely Held

#103 – Looking back on the first 99 episodes: Strong Convictions, Loosely Held

Peter Attia MD

An expert on aging and longevity, who was interviewed on the podcast and discussed the potential of Metformin.

#35 – Nir Barzilai, M.D.: How to tame aging

#35 – Nir Barzilai, M.D.: How to tame aging

Peter Attia MD

Founding director of the Institute for Aging Research at Albert Einstein, leading the TAME trial and a significant expert in longevity genetics.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?

Peter Attia MD

A world expert on Metformin and its benefits, especially concerning its impact on longevity in non-diabetic individuals, and involved in the TAME study.

Dr. Peter Attia, MD — Fasting, Metformin, Athletic Performance, and More | The Tim Ferriss Show

Dr. Peter Attia, MD — Fasting, Metformin, Athletic Performance, and More | The Tim Ferriss Show

Tim Ferriss

One of the world's experts on Metformin, leading a large clinical trial to test if it's a longevity drug for non-diabetics.

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)

Peter Attia MD

Mentioned as a past podcast guest discussing aging.

300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more

300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more

Peter Attia MD

Researcher who has argued that Metformin is geroprotective and has discussed it on Peter Attia's podcast.

204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D.

204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D.

Peter Attia MD

Guest on the podcast, a physician and expert in longevity research, discussing his studies on centenarians and interventions like metformin.